The Research and Development team at CajalNeuro focuses on investigating the underlying mechanisms of neurodegenerative diseases through both experimental and computational approaches. They utilize advanced techniques in genomics, pharmacology, bioinformatics, and target validation to identify and develop potential therapeutic compounds. This multidisciplinary team works collaboratively to translate scientific discoveries into viable drug candidates, ultimately aiming to improve treatments for neurodegenerative conditions.
View all